House Sends NACDS-Backed “Gag Clause” Prohibition to President Legislation prevents restrictions on pharmacists’ ability to tell patients when they can save money on prescriptions by paying cash instead of using insurance;NACDS positions DIR fee reform as another crucial issue for lowering out-of-pocket drug costs

2018-09-25T17:03:37+00:00Sep-25-18|Categories: Press Release|Tags: , , |

The legislation will prevent restrictions on pharmacists’ ability to tell patients when they can save money on prescriptions by paying cash instead of using insurance. Meanwhile, NACDS positions DIR fee reform as another crucial issue for lowering out-of-pocket drug costs.

NACDS Lauds Senate Panel’s Action on Bill to End “Gag Clauses” S. 2554, the Patient Right to Know Drug Prices Act, helps pharmacies help patients even more in reducing out-of-pocket prescription drug costs

2018-07-25T10:45:48+00:00Jul-25-18|Categories: Press Release|Tags: , , |

The Senate Health, Education, Labor and Pensions Committee passed legislation by Sen. Sue Collins (R-ME) that would do away with efforts to prevent pharmacists from informing patients when a medication can be purchased at a lower price without using insurance.

NACDS RxIMPACT Rallies Senate Support for Action on DIR Fees Urging Senators to sign letter to HHS Secretary is the most recent action of NACDS’ grassroots advocacy program on this pressing issue

2019-02-28T16:45:00+00:00Jul-11-18|Categories: Press Release|Tags: , , , , , |

NACDS RxIMPACT pharmacy advocates are urging Senators to sign a letter to U.S. Secretary of Health and Human Services Secretary Alex Azar that is being led by Sen. Shelley Moore Capito (R-WV) and Sen. Jon Tester (D-MT).

Load More Posts